HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Translation of novel anti-cancer cytotoxicity biomarkers detected with high content analysis from an in vitro predictive model to an in vivo cell model.

Abstract
Using high content analysis (HCA), we assessed whether cytotoxicity biomarkers translate from in vitro to in vivo models using four anti-cancer drugs (arabinoside C, arsenic trioxide, doxorubicin, and mitoxantrone) and staining live cells with Hoechst 33342 for DNA (nuclear area, nuclear intensity and cell number), Fluo-4 for ionised calcium, TMRM for mitochondrial membrane potential and TOTO-3 for plasma membrane permeability. Human HepG2 hepatocytes and Jurkat T-lymphocytes were treated with 10-fold increasing concentrations of drug for 24 and 72 h. We demonstrate that HCA can be carried out on suspension cells and that this in vivo model was at least as sensitive as the in vitro model. In addition, we show that the concentration of DOX in the nucleus and its anti-cancer mechanism of action can be assessed due to its intrinsic fluorescence and its DNA intercalation in competition with the Hoechst dye. We conclude cytotoxicity biomarkers translate from the in vitro, predictive, hepatocyte model to the in vivo lymphocyte model. Thus, HCA cytotoxicity biomarkers may not only be predictive of human toxicity potential but may be translatable for detection and monitoring of subclinical toxicity.
AuthorsN T Lieggi, A Edvardsson, P J O'Brien
JournalToxicology in vitro : an international journal published in association with BIBRA (Toxicol In Vitro) Vol. 24 Issue 8 Pg. 2063-71 (Dec 2010) ISSN: 1879-3177 [Electronic] England
PMID20670680 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 Elsevier Ltd. All rights reserved.
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Antineoplastic Agents
  • Biomarkers
  • Cytotoxins
  • Doxorubicin
Topics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 (antagonists & inhibitors)
  • Antineoplastic Agents (toxicity)
  • Biological Assay (methods)
  • Biomarkers (metabolism)
  • Cytotoxins (toxicity)
  • Dose-Response Relationship, Drug
  • Doxorubicin (toxicity)
  • Hep G2 Cells
  • Humans
  • Jurkat Cells
  • Models, Biological
  • Toxicity Tests (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: